JP Morgan Healthcare Conference
Top Five Articles on 360Dx Last Week: Cepheid's Expanded FDA Clearance, JP Morgan Conference, More
Last week, readers were most interested in a story about the FDA issuing clearance with CLIA waiver to Cepheid's Xpert Xpress Multiplex Vaginal Panel.
Top Five Articles on 360Dx Last Week: JP Morgan Healthcare Conference, Cue Health Layoffs, More
Last week, readers were most interested in a story about presentations by Danaher, Abbott, and others at the 42nd JP Morgan Healthcare Conference.
Sophia Genetics Sees Profitability in Next Two Years, Touts Liquid Biopsy Potential at JP Morgan
Sophia execs said the firm added 35 new core genomics customers in the fourth quarter of 2023 and 87 over the full year.
JP Morgan Healthcare Conference, Day 3: Grail, Myriad Genetics, Bio-Techne, Quanterix
Highlights from Day 3 included an update on Grail, thoughts by Bio-Techne's incoming CEO on the company, and Quanterix’s corporate reorganization.
JP Morgan Healthcare Conference, Day 2: Danaher, Abbott, Thermo Fisher Scientific, Revvity, More
Highlights from the second day of the conference included updates on Danaher's Cepheid business and Revvity's China business.
Dec 30, 2022
Top 10 Articles on 360Dx in 2022
Jan 13, 2022